Sign in

CTTH on OTC

CTT PHARMACEUTICAL HOLDINGS, INC.

CTT PHARMACEUTICAL HOLDINGS, INC. is an American pharmaceutical preparations company based in Ottawa, active since 1996.2 Its shares trade on OTC under the symbol CTTH.2

$0.05 down 0.01 (13.56%)Price as of Oct 15, 2026 at 17:33 UTC

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerCTTH on OTC2
  • IndustryPharmaceutical Preparations2
  • HeadquartersOttawa, Canada2
  • Incorporated inFL4
  • Business address1646 W. Snow Ave Suite 138, Tampa, Fl 336064
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company4
  • Legal formCorporation2
  • LEI549300IQFHIB3AEIFE522
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 26800912

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year20142015
Operating income-$672.2K5
Net income-$672.2K6

Compare CTT PHARMACEUTICAL HOLDINGS, INC. with another company

Leadership

Who has led CTT PHARMACEUTICAL HOLDINGS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Tol Larry Van2006
  2. David John Wodar2007
  3. Gregory B. Bowes2010–2014
  4. Pankaj Modi2015

President

  1. Tol Larry Van2006
  2. Wyck Dick Van2007
  3. David John Wodar2007
  4. Gregory B. Bowes2010

Chief financial officer

  1. Bobbi-Jo Bj Gordon2006
  2. Robert G. Dinning2006–2008
  3. Gregory B. Bowes2010–2014
  4. Lucie Letellier2015

Chief operating officer

  1. Paul K. Cooper2007
2010201520202025
Board members and other officers (12)

Former names

  • Mindesta Inc.Aug 11, 2011 to Jul 21, 20154
  • INDUSTRIAL MINERALS INCMay 31, 2002 to Jul 18, 20114
  • PNW CAPITAL INCJun 2, 2000 to May 21, 20024
  • WINCHESTER MINING CORPMay 17, 2000 to May 26, 20004

Timeline

  1. Oct 9, 20268-K Change of auditor25
  2. Oct 7, 20268-K Change of auditor26
  3. Sep 23, 20268-K Entered a material agreement; Other events27
  4. Aug 12, 20268-K Other events28
  5. Jun 19, 2015New chief executive Pankaj Modi becomes CEO8
  6. Sep 30, 2010New chief executive Gregory B. Bowes becomes CEO9
  7. Oct 9, 2007New chief executive David John Wodar becomes CEO10
  8. Apr 24, 2006New chief executive Tol Larry Van becomes CEO11
  9. Nov 6, 1996Founded CTT PHARMACEUTICAL HOLDINGS, INC. is founded2

Filings

78 filings to the SEC since October 2021: 1 quarterly reports, 4 major events, 64 insider forms, 9 other. The latest 20:

  1. Oct 13, 20268-A12G EDGAR
  2. Oct 9, 20268-K EDGAR
  3. Oct 7, 20268-K EDGAR
  4. Oct 6, 20264 PRIMARY DOCUMENT EDGAR
  5. Sep 29, 20264/A PRIMARY DOCUMENT EDGAR
  6. Sep 28, 20264 PRIMARY DOCUMENT EDGAR
  7. Sep 23, 20268-K EDGAR
  8. Sep 22, 20264 PRIMARY DOCUMENT EDGAR
  9. Sep 17, 202610-Q EDGAR
  10. Sep 16, 20264 PRIMARY DOCUMENT EDGAR
  11. Sep 10, 20264 PRIMARY DOCUMENT EDGAR
  12. Sep 4, 20264 PRIMARY DOCUMENT EDGAR
  13. Sep 2, 20264 PRIMARY DOCUMENT EDGAR
  14. Aug 31, 20264 PRIMARY DOCUMENT EDGAR
  15. Aug 24, 20264 PRIMARY DOCUMENT EDGAR
  16. Aug 20, 20264 PRIMARY DOCUMENT EDGAR
  17. Aug 19, 20264 PRIMARY DOCUMENT EDGAR
  18. Aug 14, 20264 PRIMARY DOCUMENT EDGAR
  19. Aug 12, 20268-K EDGAR
  20. Aug 10, 20264 PRIMARY DOCUMENT EDGAR

The 78 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

61 open-market trades by officers, directors and large owners since October 2021: 61 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 28, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy3,400$0.06$204Form 4
Sep 22, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy10,100$0.05$505Form 4
Sep 22, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy10,100$0.05$505Form 4
Sep 16, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy10,900$0.05$545Form 4
Sep 10, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy3,500$0.05$175Form 4
Sep 4, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy9,800$0.05$490Form 4
Sep 2, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy3,000$0.05$150Form 4
Aug 31, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy3,500$0.05$175Form 4
Aug 24, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy2,100$0.06$126Form 4
Aug 20, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy11,500$0.05$575Form 4
Aug 19, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy10,000$0.06$600Form 4
Aug 14, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy1,800$0.06$108Form 4
Aug 7, 2026CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy7,700$0.07$539Form 4
Dec 17, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy8,300$0.06$498Form 4
Nov 20, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy200,000$0.04$8.0KForm 4
Nov 20, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy62,900$0.04$2.5KForm 4
Oct 31, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy7,000$0.06$420Form 4
Sep 23, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy6,815$0.06$409Form 4
Aug 2, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy44,085$0.05$2.2KForm 4
Aug 1, 2025CTT PHARMACEUTICAL HOLDINGS, INC.CEOBuy15,800$0.04$632Form 4

All 61 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

SEC filer profile

How CTT PHARMACEUTICAL HOLDINGS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCTT PHARMACEUTICAL HOLDINGS, INC.1
  • CIK0001035422
  • Employer ID (EIN)11-37639741
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Incorporated inFlorida1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1646 W. Snow Ave Suite 138, Tampa, FL 336061
  • Phone813-606-00601
  • Shares outstanding59,722,232 as of Sep 11, 20267
  • On EDGAR sinceMay 17, 20001
  • Filings413 in all: 4 (96), 8-K (85), 10-Q (26), 3 (26), 10QSB (22), UPLOAD (21), CORRESP (15), NT 10-Q (14)1
    All 37 form types

    10QSB/A (11), 8-K/A (9), 10-K (8), 10KSB (7), 5 (7), 10-K/A (6), 10KSB/A (6), NT 10-K (6), S-1/A (6), 4/A (5), DEF 14A (5), 8-K12G3/A (4), S-8 POS (3), SC 13D (3), 10-Q/A (2), 8-K12G3 (2), DEF 14C (2), PRE 14A (2), PRE 14C (2), SC 14F1 (2), SC 14F1/A (2), 15-12G (1), 3/A (1), 8-A12G (1), DEFA14A (1), EFFECT (1), S-1 (1), S-8 (1), SB-2 (1)

  • Latest filingsAnnual report (10-K) Apr 14, 2015
    Quarterly report (10-Q) Sep 17, 2026
    Proxy statement (DEF 14A) May 3, 2012
    Latest 8-K (8-K) Oct 9, 2026

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
    Yahoo FinanceCTTH quote
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
    SEC EDGAROther events